A Pilot Study to Evaluate the Clinical Effectiveness and Safety of the VFIX Device as Treatment for Apical Prolapse

Inclusion Criteria: * Age greater than or equal to 18 years * Subjects of child bearing potential have a negative blood or urine pregnancy test prior to the procedure and subject has completed childbearing * Subject with apical prolapse at stage II or more and requiring treatment (C should be at least -1 cm) * On reduction of the apical prolapse, leading edge of prolapse should be at or above the hymen * If applicable, subject has small/normal size uterus and there is no elongation of the cervix as determined by clinical assessment * The vaginal apex can reach the Sacrospinous Ligament (SSL) on exam * Subjects are allowed concurrent incontinence procedure as required * Concurrent perineal repairs and excision of excess vaginal tissue repairs as required * Agrees to participate in the study, including completion of all study-related procedures, evaluations and questionnaires, and documents this agreement by signing the Ethics Committee approved informed consent Exclusion Criteria: * Additional surgical intervention for POP repairs concurrent to the VFIX procedure (including, but not limited to sacrocolpopexy, paravaginal repair, colporrhaphy, mesh repair, etc) * Experimental drug or experimental medical device within 3 months prior to the planned procedure * Active genital, urinary or systemic infection at the time of the surgical procedure. Surgery may be delayed in such subjects until the infection is cleared. * Previous hysterectomy within 6 months of scheduled surgery. * Coagulation disorder or on therapeutic anticoagulant therapy (except aspirin) at the time of surgery * Nursing or pregnant * Presence of cancers of the vagina, cervix, or uterus * In the investigator's opinion, any medical condition or psychiatric illness that could potentially be life threatening or affect their ability to complete the study visits according to this protocol